IBDEI0D4 ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17474,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17474,1,4,0)
 ;;=4^078.10
 ;;^UTILITY(U,$J,358.3,17474,1,5,0)
 ;;=5^Warts
 ;;^UTILITY(U,$J,358.3,17474,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,17475,0)
 ;;=706.8^^125^1077^70
 ;;^UTILITY(U,$J,358.3,17475,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17475,1,4,0)
 ;;=4^706.8
 ;;^UTILITY(U,$J,358.3,17475,1,5,0)
 ;;=5^Xerosis
 ;;^UTILITY(U,$J,358.3,17475,2)
 ;;=^271931
 ;;^UTILITY(U,$J,358.3,17476,0)
 ;;=710.1^^125^1077^53
 ;;^UTILITY(U,$J,358.3,17476,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17476,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,17476,1,5,0)
 ;;=5^Scleroderma
 ;;^UTILITY(U,$J,358.3,17476,2)
 ;;=Scleroderma^108590
 ;;^UTILITY(U,$J,358.3,17477,0)
 ;;=707.21^^125^1077^41
 ;;^UTILITY(U,$J,358.3,17477,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17477,1,4,0)
 ;;=4^707.21
 ;;^UTILITY(U,$J,358.3,17477,1,5,0)
 ;;=5^Pressure Ulcer,Stage I
 ;;^UTILITY(U,$J,358.3,17477,2)
 ;;=^336649
 ;;^UTILITY(U,$J,358.3,17478,0)
 ;;=707.22^^125^1077^42
 ;;^UTILITY(U,$J,358.3,17478,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17478,1,4,0)
 ;;=4^707.22
 ;;^UTILITY(U,$J,358.3,17478,1,5,0)
 ;;=5^Pressure Ulcer,Stage II
 ;;^UTILITY(U,$J,358.3,17478,2)
 ;;=^336650
 ;;^UTILITY(U,$J,358.3,17479,0)
 ;;=707.23^^125^1077^43
 ;;^UTILITY(U,$J,358.3,17479,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17479,1,4,0)
 ;;=4^707.23
 ;;^UTILITY(U,$J,358.3,17479,1,5,0)
 ;;=5^Pressure Ulcer,Stage III
 ;;^UTILITY(U,$J,358.3,17479,2)
 ;;=^336651
 ;;^UTILITY(U,$J,358.3,17480,0)
 ;;=707.24^^125^1077^44
 ;;^UTILITY(U,$J,358.3,17480,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17480,1,4,0)
 ;;=4^707.24
 ;;^UTILITY(U,$J,358.3,17480,1,5,0)
 ;;=5^Pressure Ulcer,Stage IV
 ;;^UTILITY(U,$J,358.3,17480,2)
 ;;=^336652
 ;;^UTILITY(U,$J,358.3,17481,0)
 ;;=707.25^^125^1077^46
 ;;^UTILITY(U,$J,358.3,17481,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17481,1,4,0)
 ;;=4^707.25
 ;;^UTILITY(U,$J,358.3,17481,1,5,0)
 ;;=5^Pressure Ulcer,Unstagebl
 ;;^UTILITY(U,$J,358.3,17481,2)
 ;;=^336653
 ;;^UTILITY(U,$J,358.3,17482,0)
 ;;=707.20^^125^1077^45
 ;;^UTILITY(U,$J,358.3,17482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17482,1,4,0)
 ;;=4^707.20
 ;;^UTILITY(U,$J,358.3,17482,1,5,0)
 ;;=5^Pressure Ulcer,Stage NOS
 ;;^UTILITY(U,$J,358.3,17482,2)
 ;;=^336761
 ;;^UTILITY(U,$J,358.3,17483,0)
 ;;=V18.0^^125^1078^15
 ;;^UTILITY(U,$J,358.3,17483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17483,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,17483,1,5,0)
 ;;=5^Family h/o Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,17483,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,17484,0)
 ;;=V16.0^^125^1078^8
 ;;^UTILITY(U,$J,358.3,17484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17484,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,17484,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,17484,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,17485,0)
 ;;=V16.1^^125^1078^9
 ;;^UTILITY(U,$J,358.3,17485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17485,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,17485,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,17485,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,17486,0)
 ;;=V19.6^^125^1078^2
 ;;^UTILITY(U,$J,358.3,17486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17486,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,17486,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,17486,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,17487,0)
 ;;=V18.2^^125^1078^3
 ;;^UTILITY(U,$J,358.3,17487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17487,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,17487,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,17487,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,17488,0)
 ;;=V17.5^^125^1078^5
 ;;^UTILITY(U,$J,358.3,17488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17488,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,17488,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,17488,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,17489,0)
 ;;=V17.7^^125^1078^4
 ;;^UTILITY(U,$J,358.3,17489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17489,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,17489,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,17489,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,17490,0)
 ;;=V19.0^^125^1078^6
 ;;^UTILITY(U,$J,358.3,17490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17490,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,17490,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,17490,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,17491,0)
 ;;=V16.3^^125^1078^7
 ;;^UTILITY(U,$J,358.3,17491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17491,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,17491,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,17491,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,17492,0)
 ;;=V16.41^^125^1078^10
 ;;^UTILITY(U,$J,358.3,17492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17492,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,17492,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,17492,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,17493,0)
 ;;=V16.42^^125^1078^11
 ;;^UTILITY(U,$J,358.3,17493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17493,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,17493,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,17493,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,17494,0)
 ;;=V16.43^^125^1078^12
 ;;^UTILITY(U,$J,358.3,17494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17494,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,17494,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,17494,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,17495,0)
 ;;=V19.5^^125^1078^13
 ;;^UTILITY(U,$J,358.3,17495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17495,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,17495,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,17495,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,17496,0)
 ;;=V19.2^^125^1078^14
 ;;^UTILITY(U,$J,358.3,17496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17496,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,17496,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,17496,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,17497,0)
 ;;=V17.3^^125^1078^16
 ;;^UTILITY(U,$J,358.3,17497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17497,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,17497,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,17497,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,17498,0)
 ;;=V16.6^^125^1078^17
 ;;^UTILITY(U,$J,358.3,17498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17498,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,17498,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,17498,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,17499,0)
 ;;=V18.61^^125^1078^19
 ;;^UTILITY(U,$J,358.3,17499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17499,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,17499,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,17499,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,17500,0)
 ;;=V17.0^^125^1078^20
 ;;^UTILITY(U,$J,358.3,17500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17500,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,17500,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,17500,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,17501,0)
 ;;=V19.4^^125^1078^21
 ;;^UTILITY(U,$J,358.3,17501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17501,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,17501,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,17501,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,17502,0)
 ;;=V17.1^^125^1078^22
 ;;^UTILITY(U,$J,358.3,17502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17502,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,17502,1,5,0)
 ;;=5^Family h/o Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,17502,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,17503,0)
 ;;=V16.8^^125^1078^18
 ;;^UTILITY(U,$J,358.3,17503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17503,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,17503,1,5,0)
 ;;=5^Family h/o Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,17503,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,17504,0)
 ;;=V11.1^^125^1078^41
 ;;^UTILITY(U,$J,358.3,17504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17504,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,17504,1,5,0)
 ;;=5^Personal h/o Affective Disorder
 ;;^UTILITY(U,$J,358.3,17504,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,17505,0)
 ;;=V15.89^^125^1078^49
 ;;^UTILITY(U,$J,358.3,17505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17505,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,17505,1,5,0)
 ;;=5^Personal h/o Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,17505,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,17506,0)
 ;;=V11.3^^125^1078^42
 ;;^UTILITY(U,$J,358.3,17506,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17506,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,17506,1,5,0)
 ;;=5^Personal h/o Alcoholism
 ;;^UTILITY(U,$J,358.3,17506,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,17507,0)
 ;;=V15.07^^125^1078^43
 ;;^UTILITY(U,$J,358.3,17507,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17507,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,17507,1,5,0)
 ;;=5^Personal h/o Allerlgy to Latex
 ;;^UTILITY(U,$J,358.3,17507,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,17508,0)
 ;;=V13.4^^125^1078^44
 ;;^UTILITY(U,$J,358.3,17508,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17508,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,17508,1,5,0)
 ;;=5^Personal h/o Arthritis
 ;;^UTILITY(U,$J,358.3,17508,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,17509,0)
 ;;=V12.72^^125^1078^45
 ;;^UTILITY(U,$J,358.3,17509,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17509,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,17509,1,5,0)
 ;;=5^Personal h/o Colon Polyps
 ;;^UTILITY(U,$J,358.3,17509,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,17510,0)
 ;;=V12.59^^125^1078^46
 ;;^UTILITY(U,$J,358.3,17510,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17510,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,17510,1,5,0)
 ;;=5^Personal h/o Congestive Heart Failure
